Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Multiple myeloma: present and future.

Mohamad A Hussein1, Jaya V Juturi, Isador Lieberman

  • 1Myeloma Research Program, Cleveland Clinic Taussig Cancer Center, Cleveland, Ohio 44195, USA. husseim@ccf.org

Current Opinion in Oncology
|January 16, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Clinical Outcomes of Lumbar Fusions Using Transfacet Screws.

Cureus·2026
Same author

Clinical Outcomes for 52 Patients Treated with V-STRUT® Transpedicular Device for Osteoporotic and Pathologic Vertebral Compression Fractures in the United States.

Pain physician·2025
Same author

Scoping review of robotics technology in spinal surgery with highlights of the Annual Seattle Science Foundation Course.

Annals of translational medicine·2025
Same author

Randomized Trial of Augmented Pelvic Fixation in Patients Undergoing Thoracolumbar Fusion for Adult Spine Deformity: Initial Results from a Multicenter Randomized Trial.

World neurosurgery·2024
Same author

Robotic Sacroiliac Fixation Technique for Triangular Titanium Implant in Adult Degenerative Scoliosis Surgery: 2-Dimensional Operative Video.

Operative neurosurgery (Hagerstown, Md.)·2021
Same author

Functional Ability Classification Based on Moderate and Severe Kinesophobia and Demoralization Scores in Degenerative Spine Patients.

Spine·2021
Same journal

Artificial intelligence-augmented robotic surgery in gynecologic oncology: intraoperative assistance and analytics.

Current opinion in oncology·2026
Same journal

Artificial intelligence in cervical cancer screening and triage: a role-stratified systematic review and bivariate meta-analysis.

Current opinion in oncology·2026
Same journal

Deep learning assisting the surgical management of gynecologic cancers.

Current opinion in oncology·2026
Same journal

Pain management in pancreatic cancer: time to change our strategy!

Current opinion in oncology·2026
Same journal

Systemic radionuclide treatments in gastro-entero-pancreatic neuroendocrine tumours.

Current opinion in oncology·2026
Same journal

Lifestyle medicine for cancer survivorship.

Current opinion in oncology·2026
See all related articles

Multiple myeloma, a bone marrow cancer, involves plasma cells and is driven by Interleukin-6. Researchers are developing therapies to manage this condition, aiming for a chronic, manageable disease state.

Area of Science:

  • Hematology
  • Oncology
  • Immunology

Background:

  • Multiple myeloma is a significant hematologic malignancy, accounting for 10% of all cancers.
  • It is the second most common hematologic cancer in the United States.
  • Interleukin-6 (IL-6) is a key cytokine crucial for myeloma cell survival and proliferation.

Purpose of the Study:

  • To investigate the role of Interleukin-6 in multiple myeloma pathogenesis.
  • To explore therapeutic strategies targeting the tumor microenvironment.

Main Methods:

  • Analysis of cytokine production in the bone marrow microenvironment.
  • Investigation of cell-to-cell interactions between myeloma and stromal cells.

Main Results:

Related Experiment Videos

  • Close contact between myeloma and bone marrow stromal cells stimulates high Interleukin-6 production.
  • Interleukin-6 supports myeloma cell growth and protects against chemotherapy-induced apoptosis.

    • Conclusions:

    • Targeting Interleukin-6 and the tumor microenvironment holds promise for managing multiple myeloma.
    • The goal is to transform multiple myeloma into a chronic, manageable condition allowing patients a normal lifestyle.